Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 6
1947 2
1948 4
1949 1
1951 1
1969 3
1970 1
1976 1
1979 1
1983 3
1984 1
1985 4
1986 2
1987 5
1988 2
1989 2
1990 1
1991 8
1992 7
1993 8
1994 7
1995 6
1996 11
1997 7
1998 15
1999 8
2000 8
2001 9
2002 16
2003 5
2004 10
2005 19
2006 19
2007 15
2008 25
2009 30
2010 19
2011 21
2012 23
2013 22
2014 23
2015 30
2016 31
2017 34
2018 33
2019 37
2020 62
2021 68
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

639 results
Results by year
Filters applied: . Clear all
Page 1
Management of ascites in children.
Lane ER, Hsu EK, Murray KF. Lane ER, et al. Among authors: hsu ek. Expert Rev Gastroenterol Hepatol. 2015;9(10):1281-92. doi: 10.1586/17474124.2015.1083419. Epub 2015 Sep 1. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26325252 Review.
The Exosome Total Isolation Chip.
Liu F, Vermesh O, Mani V, Ge TJ, Madsen SJ, Sabour A, Hsu EC, Gowrishankar G, Kanada M, Jokerst JV, Sierra RG, Chang E, Lau K, Sridhar K, Bermudez A, Pitteri SJ, Stoyanova T, Sinclair R, Nair VS, Gambhir SS, Demirci U. Liu F, et al. Among authors: hsu ec. ACS Nano. 2017 Nov 28;11(11):10712-10723. doi: 10.1021/acsnano.7b04878. Epub 2017 Nov 1. ACS Nano. 2017. PMID: 29090896 Free PMC article.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Samoilova O, Novak J, Ben-Yehuda D, Strugov V, Gill D, Gribben JG, Hsu E, Lih CJ, Zhou C, Clow F, James DF, Styles L, Flinn IW. Moreno C, et al. Among authors: hsu e. Lancet Oncol. 2019 Jan;20(1):43-56. doi: 10.1016/S1470-2045(18)30788-5. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522969 Clinical Trial.
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.
Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, Peehl DM, Zoubeidi A, Gambhir SS, Kunder CA, Pitteri SJ, Brooks JD, Stoyanova T. Hsu EC, et al. Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2032-2042. doi: 10.1073/pnas.1905384117. Epub 2020 Jan 13. Proc Natl Acad Sci U S A. 2020. PMID: 31932422 Free PMC article.
Clinical Implications of Opioid Therapy.
Anthony C, Haroutunian A, Hsu E, Ashford J, Przkora R, Ojode T, Trescot A. Anthony C, et al. Among authors: hsu e. Cancer Treat Res. 2021;182:107-124. doi: 10.1007/978-3-030-81526-4_8. Cancer Treat Res. 2021. PMID: 34542879
The invention of lymphocytes.
Hsu E. Hsu E. Curr Opin Immunol. 2011 Apr;23(2):156-62. doi: 10.1016/j.coi.2010.12.007. Epub 2011 Jan 10. Curr Opin Immunol. 2011. PMID: 21227671 Free PMC article. Review.
639 results